AstraZeneca (AZ) has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for ...
uniQure’s investigational gene therapy has been shown to slow the progression of Huntington’s disease, according to new ...
Johnson & Johnson (J&J) has received approvals from both the European Commission (EC) and US Food and Drug Administration (FDA) for its tuberculosis (TB) treatment, Sirturo (bedaquiline). The EC has ...
At last Thursday’s Communiqué Awards, a truly regrettable situation occurred when the winner of the Excellence in Media Relations category was revealed. After the judging of this category had ...
Following the launch of Seijaku at last Thursday’s Communiqué Awards, we are delighted to announce the winner of the Seijaku competition. Pippa Perrett, senior medical writer from Lumanity, has won a ...
A new study conducted by researchers at Case Western Reserve University School of Medicine, Ohio, has revealed that patients living with type 2 diabetes (T2D) treated with semaglutide are less likely ...
Global medical communications agency Emotive has launched a new visual identity and branding to reflect its evolution over the past ten years. Emotive said the fresh identity captures its “essence of ...
Approximately 16.5 million adults and 9.6 million children in the US are affected by the inflammatory skin condition The US Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ ...
The World Health Organization (WHO) has published a new implementation toolkit for the Intersectoral global action plan on epilepsy and other neurological disorders (IGAP) to help countries improve ...
Johnson & Johnson (J&J) and Legend Biotech have shared positive results from a late-stage study of their BCMA-directed T-cell immunotherapy Carvykti (ciltacabtagene autoleucel) in previously-treated ...
Researchers from the Wellcome Sanger Institute, the Institute of Cancer Research and the University of Cambridge have identified thousands of high-risk cancer gene variants, along with a potential ...